Linical
Linical Co., Ltd. is a Japan-headquartered, publicly traded global Contract Research Organization (CRO) providing full-service Phase I–IV clinical trial management to mid-sized biopharmaceutical and biotechnology sponsors across 30+ countries in Asia Pacific, Europe, and the Americas.
- Company typePublic
- Founded2004
- HeadquartersYodogawa, Japan
- Headcount501–1,000
- GTM typeB2B
- OfferingServices
Linical firmographics
Firmographics- Name
- Linical
- Legal name
- Linical Co., Ltd.
- Website
- https://linical.com
- Company type
- Public
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Linical Co., Ltd. is a Japan-headquartered, publicly traded global Contract Research Organization (CRO) providing full-service Phase I–IV clinical trial management to mid-sized biopharmaceutical and biotechnology sponsors across 30+ countries in Asia Pacific, Europe, and the Americas.
- Ownership category
- akta.pro rank
Linical industry classification
Industry- Product category
- Contract Research Organization Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA), Regulatory Operations & Publishing (eCTD, RIM, Submission Management) (HLAGAKAC), Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)
Keywords
Where Linical is headquartered
LocationHeadquarters
- HQ city
- Yodogawa
- HQ country
- Japan
- HQ region
- Asia
Offices8 records
Markets served
Linical business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- CRO Services: Full-service Contract Research Organization providing comprehensive clinical trial management services including drug development strategy, clinical trial management, and functional service provider (FSP) solutions. Revenue is generated through project-based contracts with biopharmaceutical clients across all phases of clinical development.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Linical product offering
Product offeringCore offering
Linical is a global Contract Research Organization (CRO) that provides full-service clinical development support to biopharmaceutical companies across Phase I through Phase IV trials. Its core offerings are organized into two service pillars: Drug Development Strategy (protocol development, regulatory affairs, quality assurance, medical writing) and Clinical Trial Management (feasibility, project management, clinical monitoring, pharmacovigilance, patient recruitment, biometrics). The company delivers these services across therapeutic areas including oncology, neurology, immunology and vaccines, endocrinology and metabolic disorders, rare disease, pediatrics, and biosimilars, supported by global operations in approximately 30 countries.
Product overview
Linical is an award-winning, global CRO (Contract Research Organization) offering a full-service, integrated clinical development platform spanning drug development strategy and clinical trial management services. The platform is organized around two core service pillars: Drug Development Strategy (including Protocol Development & Study Design, Regulatory Affairs, Regulatory Consulting, Quality Assurance, and Medical Writing) and Clinical Trial Management (including Feasibility & Study Start Up, Project Management, Medical Affairs & Pharmacovigilance, Clinical Monitoring, Patient Recruitment, Biometrics, and Training Academy). The company provides these services across five key therapeutic areas: Oncology, Neurology & Psychiatry, Immunology & Vaccine, Endocrinology & Metabolic, and Other Focus Areas (Biosimilars, Rare Disease, Pediatrics). Linical also offers Functional Services Provider (FSP) staffing solutions as an add-on service. The company operates across The Americas, Europe, and Asia Pacific regions with approximately 30 countries.
Differentiator
Problem solved
Functional benefit
Products and services
- Drug Development Strategy Services Integrated drug development strategy services for biopharmaceutical sponsors covering protocol development, regulatory affairs, regulatory consulting, quality assurance, and medical writing across Japan, US, EU, and Asia-Pacific markets.
- Clinical Trial Management Services Full-service clinical trial management across Phase I-IV, including feasibility and study start-up, project management, medical affairs and pharmacovigilance, on-site and remote clinical monitoring, patient recruitment and enrollment, biometrics, and professional training academy services.
- Oncology Clinical Research Services Clinical trial services for biopharmaceutical sponsors developing oncology treatments, covering solid tumors, liquid tumors, immunotherapies, rare cancers, and early phase oncology studies.
- Neurology & Psychiatry Clinical Research Services Clinical trial services for sponsors developing CNS therapies, addressing cognitive, neurological, movement, mood, neuromuscular disorders, and pain indications.
- Immunology & Vaccine Clinical Research Services Clinical trial services for vaccine developers and immunology sponsors covering autoimmune diseases, respiratory disorders, allergies, prophylactic and therapeutic vaccines, and outbreak response studies.
- Endocrinology & Metabolic Clinical Research Services Clinical trial services for sponsors developing endocrine and metabolic treatments, covering diabetes, thyroid disorders, reproductive disorders, inherited metabolic disorders, and bone diseases.
- Rare Disease Clinical Research Services Specialized clinical trial services for sponsors developing treatments for rare and orphan diseases, employing flexible and innovative solutions to address small patient populations and complex trial designs.
- Pediatrics Clinical Research Services Clinical trial services for pediatric populations, with specialized expertise in pediatric regulatory requirements and patient recruitment strategies.
- Biosimilars Clinical Research Services Clinical trial services supporting sponsors developing biosimilars, providing comparative efficacy, safety, and immunogenicity study execution.
Quantifiable outcome
- 85%+ client retention rate demonstrating strong customer satisfaction and long-term partnerships
- +2 more outcomes
Companies that use Linical
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles4 records
Linical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Linical partnerships and signals
Strategic signalScale indicators6 records
Recent moves6 records
Expansion highlights6 records
Linical competitors and assessment
Company assessmentDirect peers
- ICON plc: ICON plc is a top-tier global CRO offering full-service clinical research across all therapeutic areas and phases. ICON directly competes with Linical for full-service clinical trial management contracts, especially in oncology and rare disease where both companies have therapeutic depth.
- Medpace Holdings: Medpace is a mid-sized, full-service CRO with strong therapeutic specialization in oncology, metabolic, and rare disease. Like Linical, Medpace positions itself as a 'right-sized' alternative to mega-CROs, making it one of the closest direct comparables in the mid-market segment.
- Parexel: Parexel is a global full-service CRO with strong therapeutic expertise in oncology, rare disease, and immunology. Parexel and Linical compete head-to-head for mid-sized biopharma clinical development contracts and FSP engagements.
- PSI CRO: PSI CRO is a privately held, full-service CRO with strong European and emerging Asia Pacific operations. PSI competes with Linical in oncology, rare disease, and FSP engagements for mid-sized biopharma sponsors.
- Syneos Health: Syneos Health is a fully integrated biopharmaceutical solutions organization offering clinical development and commercial services. Syneos competes with Linical in full-service clinical trial management and FSP offerings.
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO with therapeutic depth in CNS, oncology, rare disease, and metabolic disorders. Worldwide is one of the closest mid-market comparables to Linical in both therapeutic footprint and 'right-sized' positioning.
Broad incumbents
- IQVIA: IQVIA is the world's largest CRO with comprehensive clinical development and technology-enabled solutions across all phases and therapeutic areas. Linical competes with IQVIA primarily in mid-sized biopharma accounts seeking more personalized service than IQVIA's scale typically delivers.
- Labcorp / Covance: Labcorp's Covance Clinical Development division provides global full-service clinical trial management alongside central laboratory services. Covance competes with Linical across Phase I-IV trials and has substantially larger scale and global site coverage.
- Charles River Laboratories: Charles River provides preclinical and clinical development services with global reach and strong Asia Pacific presence. Charles River overlaps with Linical in early-phase clinical trials and discovery-to-Phase II handoffs.
Emerging players
- Clinsys Clinical Research: Clinsys Clinical Research is a mid-sized CRO offering clinical development and post-approval services globally. As a smaller CRO with full-service ambitions, Clinsys is comparable in scale and therapeutic breadth to Linical.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Linical social profiles
Digital presenceLinical compliance and trust
Trust signalCompliance1 record
Linical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Linical leadership team
Management profileNumber of profiles
Profiles8 records
Linical subsidiaries and ownership
Company hierarchySubsidiaries7 records
Linical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Linical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Linical
What does Linical do?
Linical is a global Contract Research Organization (CRO) that provides full-service clinical development support to biopharmaceutical companies across Phase I through Phase IV trials. Its core offerings are organized into two service pillars: Drug Development Strategy (protocol development, regulatory affairs, quality assurance, medical writing) and Clinical Trial Management (feasibility, project management, clinical monitoring, pharmacovigilance, patient recruitment, biometrics). The company delivers these services across therapeutic areas including oncology, neurology, immunology and vaccines, endocrinology and metabolic disorders, rare disease, pediatrics, and biosimilars, supported by global operations in approximately 30 countries.
Is Linical a public or private company?
Linical is a public company. It is classified as public and is currently operating.
When was Linical founded?
Linical was founded in 2004. It employs 501 to 1,000 people.
Where is Linical based?
Linical is headquartered in Yodogawa, Japan, in the Asia region.
How does Linical make money?
One revenue line is on record: CRO Services.
Who are Linical's main competitors?
Direct peers on record are ICON plc, Medpace Holdings, Parexel, PSI CRO, Syneos Health and Worldwide Clinical Trials. Broad incumbents are IQVIA, Labcorp / Covance and Charles River Laboratories. Clinsys Clinical Research is listed as an emerging player.
Does Linical have an API?
No public API is recorded for Linical.
What industry is Linical in?
Linical's product category is Contract Research Organization Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 54171 and its SIC code is 8731.